News Sentiment

DTIL sentiment intelligence

Precision BioSciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 65 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.76 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 57

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+7.1% over one week, +43.6% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Trading the Move, Not the Narrative: (DTIL) Edition

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 7.1% Price confirming higher
Trend fit Trend active 43.6% over four weeks
Fair value 8.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 22
Neutral 37
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 57
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 8
Business Wire 7
GuruFocus 5
Stock Titan 5
www.marketscreener.com 3
TradingKey 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 21
Analyst action 4
Deals and strategy 1
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 65
Stock Traders Daily Direct company coverage

Trading the Move, Not the Narrative: (DTIL) Edition

This article analyzes Precision Biosciences Inc. (NASDAQ: DTIL), highlighting weak near-term sentiment with a mid-channel oscillation pattern. It identifies an exceptional 62.0:1 risk-reward short setup and provides institutional trading strategies for different risk profiles. Th

Tone
Positive 60/100
Event
Market update
Published
15 Jul 2026 07:34
Source
Stock Traders Daily
Quartr Direct company coverage

Precision BioSciences (DTIL) Proxy filing Summary

Precision BioSciences (DTIL) will hold its annual meeting virtually on May 21, 2026, where shareholders will vote on critical proposals including the election of two Class I directors, auditor ratification, executive compensation, amendments to the 2019 Incentive Award Plan, offi

Tone
Positive 62/100
Event
Market update
Published
13 Jul 2026 03:41
Source
Quartr
MarketBeat Direct company coverage

Precision BioSciences (DTIL) Short Interest & Short Float | Updated Jul 2026 $DTIL

As of June 30, 2026, Precision BioSciences (DTIL) had 2.30 million shares sold short, representing 9.15% of its public float, marking an 18.16% increase from the prior report. The short interest ratio is 3.5 days to cover, indicating a generally positive sentiment. The article pr

Tone
Negative 38/100
Event
Market update
Published
11 Jul 2026 03:33
Source
MarketBeat
GuruFocus Direct company coverage

Precision BioSciences Grants Stock Units to New Employees Amid G

Precision BioSciences (DTIL) has granted 114,622 restricted stock units to three new employees to attract and retain talent in the competitive biotechnology sector. The company's stock is significantly overvalued according to GuruFocus's GF Value™ of $1.83 compared to its current

Tone
Negative 39/100
Event
Market update
Published
10 Jul 2026 16:39
Source
GuruFocus
GuruFocus Direct company coverage

Precision BioSciences Grants Stock Units to New Employees Amid Growth

Precision BioSciences (DTIL) recently granted 114,622 restricted stock units to three new employees as an incentive to attract and retain talent in the competitive biotechnology sector. While this move aims to align employee and shareholder interests, GuruFocus suggests the stock

Tone
Negative 30/100
Event
Market update
Published
10 Jul 2026 14:06
Source
GuruFocus
BioSpace Direct company coverage

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 10, 2026

Precision BioSciences, Inc. announced the grant of inducement awards consisting of 114,622 restricted stock units (RSUs) to three new employees. These awards were approved by the Compensation Committee and granted under Nasdaq Listing Rule 5635(c)(4) to incentivize their employme

Tone
Positive 67/100
Event
Market update
Published
10 Jul 2026 12:10
Source
BioSpace
GuruFocus Direct company coverage

Precision BioSciences (DTIL) Grants Inducement Awards to New Hires

Precision BioSciences (DTIL) has granted inducement awards, totaling 114,622 restricted stock units, to three new employees to attract and retain talent in the competitive biotechnology sector. Despite this strategic move, the company faces challenges including a declining revenu

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 11:10
Source
GuruFocus
TradingView Direct company coverage

Precision BioSciences, Inc. Actuals & Estimates (TRADEGATE:PBS0)

This article provides financial actuals and estimates for Precision BioSciences, Inc. (PBS0) traded on the TRADEGATE exchange. It covers analyst forecasts, historical stock prices, upcoming earnings dates, and recent financial performance including earnings per share, revenue, an

Tone
Neutral 50/100
Event
Earnings
Published
10 Jul 2026 00:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Precision BioSciences, Inc. – NASDAQ:DTIL

This article displays financial information for Precision BioSciences, Inc. (NASDAQ: DTIL) regarding its enterprise value to revenue forward. The content is presented within the TradingView platform, noting that the market is closed and no trades have occurred for the stock.

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 12:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Precision BioSciences, Inc. – NASDAQ:DTIL

This article focuses on the enterprise value to EBITDA forward for Precision BioSciences, Inc. (NASDAQ: DTIL). It presents this financial metric within the context of the company's profile on TradingView, indicating that specific value and change data is available. The rest of th

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 06:39
Source
TradingView
Minichart Direct company coverage

Precision BioSciences Updates Investors with Latest Corporate Deck in July 2026 SEC 8-K Filing

Precision BioSciences (NASDAQ: DTIL) filed an 8-K with the SEC in July 2026, releasing an updated corporate deck and detailing significant clinical advancements. Key updates include positive liver biopsy data from its PBGENE-HBV program for chronic hepatitis B, showing direct eli

Tone
Positive 75/100
Event
Market update
Published
01 Jul 2026 13:10
Source
Minichart
Stock Titan Direct company coverage

Precision BioSciences (NASDAQ: DTIL) shares HBV data, DMD trial timeline

Precision BioSciences (NASDAQ: DTIL) has furnished an updated corporate deck detailing progress in its gene-editing programs. The company reported liver biopsy data for its PBGENE-HBV chronic hepatitis B treatment, showing a 1-log reduction in cccDNA-derived transcripts, with the

Tone
Positive 63/100
Event
Market update
Published
01 Jul 2026 11:10
Source
Stock Titan
www.marketscreener.com Direct company coverage

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Index

Precision BioSciences, Inc. (NasdaqCM: DTIL), a clinical-stage gene editing company, has been added to the Russell 2000 Index. The company utilizes its proprietary ARCUS genome editing platform to develop in vivo gene editing therapies for various genetic and infectious diseases,

Tone
Positive 74/100
Event
Market update
Published
29 Jun 2026 18:39
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Value Benchmark

Precision BioSciences, Inc. (NasdaqCM: DTIL), a clinical-stage gene editing company, has been added to the Russell 2000 Value Benchmark. This inclusion follows news that the company was also added to the broader Russell 2000 Index. Precision BioSciences utilizes its proprietary A

Tone
Positive 75/100
Event
Market update
Published
29 Jun 2026 15:39
Source
www.marketscreener.com
Investing.com Nigeria Direct company coverage

Precision BioSciences added to Russell 2000 index By Investing.com

Precision BioSciences Inc. (NASDAQ:DTIL) has been added to the Russell 2000 Index, effective at the close of U.S. equity markets on Friday, June 26, 2026. This inclusion is expected to increase the company's visibility with institutional investors, especially as it advances two c

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 12:09
Source
Investing.com Nigeria
marketscreener.com Direct company coverage

Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell Small Cap Comp Value Benchmark

Precision BioSciences, Inc. (NasdaqCM:DTIL), a clinical-stage gene editing company, has been added to the Russell Small Cap Comp Value Benchmark. The company utilizes its proprietary ARCUS genome editing platform to develop therapies for genetic and infectious diseases, with a le

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 12:09
Source
marketscreener.com
GuruFocus Direct company coverage

Precision BioSciences (DTIL) Joins Russell 2000 Index, Highlighting Growth Potential

Precision BioSciences (DTIL) is set to join the Russell 2000 Index, a move expected to boost its visibility among institutional investors. The company is advancing clinical initiatives for chronic hepatitis B and Duchenne muscular dystrophy. Despite this milestone and moderate fi

Tone
Positive 60/100
Event
Market update
Published
29 Jun 2026 11:39
Source
GuruFocus
Business Wire Direct company coverage

Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors

Precision BioSciences, a clinical stage gene editing company, announced its inclusion in the Russell 2000® Index, effective June 26, 2026. This addition is expected to increase market visibility with institutional investors, coming at a critical time as the company advances two c

Tone
Positive 70/100
Event
Market update
Published
29 Jun 2026 10:39
Source
Business Wire
www.marketscreener.com Direct company coverage

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000 Value Benchmark

Precision BioSciences, Inc. (NasdaqCM: DTIL) has been added to the Russell 3000 Value Benchmark, according to an announcement published on June 28, 2026. This inclusion follows several other recent additions to Russell indices, including the Russell 2000 Index and Russell 2500 In

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 23:10
Source
www.marketscreener.com
TradingView Direct company coverage

Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0)

This article provides financial actuals and estimates for Precision BioSciences, Inc. (PBS0) traded on the Dusseldorf Stock Exchange. It includes analyst price forecasts, historical stock prices, earnings reports, revenue figures, net income, and other financial metrics like EBIT

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 04:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Precision BioSciences, Inc. – NASDAQ:DTIL

The article provides a simple statement about the "Price to sales forward" for Precision BioSciences, Inc. (NASDAQ: DTIL) as listed on TradingView. It appears to be an entry from a financial data platform, showing basic company and market information rather than an analytical pie

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 11:41
Source
TradingView
TradingView Direct company coverage

Precision BioSciences, Inc. Actuals & Estimates (NASDAQ:DTIL)

This article provides a financial overview and analyst estimates for Precision BioSciences, Inc. (NASDAQ: DTIL). It covers the company's stock performance, market capitalization, volatility, and upcoming earnings report. The piece also includes answers to frequently asked questio

Tone
Positive 64/100
Event
Earnings
Published
26 Jun 2026 09:10
Source
TradingView